AIxMed, Inc.
waiting

Why AIxMed?

The promise of AI and machine learning to transform healthcare is great and unfulfilled.

Our founding team saw this from both sides: Samuel Chen from the tech side as an AI expert and executive for ASUS and Compal, and TJ Liu from the medical side as a trained physician and serial medtech entrepreneur.

We realized that, for AI to impact healthcare, it had to offer intuitive tools to not only simplify clinical workflows, but also reduce care burden and improve outcomes.

We founded AIxMed to build just such tools. We begin with a computational platform that helps pathologists visualize and discover insights for cell samples in seconds.

COVID-19

Chief Executive Officer, President & Co-Founder

Samuel Chen

Bringing over 25 years of software development experience to the team, Samuel Chen is the president and CEO for AIxMed, a Silicon Valley startup company founded in June 2018 to apply machine learning to medicine. He was the Vice President of Software Development at Trend Micro and helped establish the company as one of the top 3 information security companies in the world and Taiwan’s #1 software company. He also held executive leadership roles at ASUSTek and Compal and founded the Compal AI Lab. Samuel graduated from National Chiao-Tung University and attained his master’s in computer science from the University of Southern California.

COVID-19

Chief Operating Officer & Co-Founder

Tien-Jen Liu

Tien-Jen Liu is an experienced attending physician with a proven history in the biotechnology industry. He is skilled in clinical research, medical device development, clinical study, and business development. He is also the director of the biomedical innovation program at a medical university.

COVID-19

SVP Business Development

Stephen Hess

Steph Hess is an experienced business development professional bringing two decades of IVD and life science experience to the team in both Product and Business Development. He has consulted for dozens of start-up companies and helped introduce multiple products to the market. He was previously VP Global Business Development at Invetech and VP Global Sales and Marketing at IDEX Health and Science. Steph has an Engineering Degree from Rutgers University and a MS in Management from WPI.

Advisory Board

Mr. Shawn Marcell

Mr. Shawn Marcell

  • President/CEO, Torus Biosystems
  • Entrepreneur In Residence/Visiting Scholar, Wyss Institute, Harvard
Dr. Yuh-Geng Tsay

Dr. Yuh-Geng Tsay

  • Venture Partner, VIVO Capital
  • Former President/SVP Immunodiagnostics, Thermo Fisher
Dr. HJ Chang

Dr. HJ Chang

  • Chairman & CEO, Taiwan Global BioFund
  • Former Deputy Minister, Dept of Health, Taiwan
Ms. Laura Housman

Ms. Laura Housman

  • Chief Commercial & Operations Officer, Olaris, Inc.
  • Former Head/VP, Access Outcomes and Population Health, Exact Sciences
  • Adjunct Faculty, Massachusetts College of Pharmacy and Health Sciences
Dr. Judy Chou

Dr. Judy Chou

  • President and CEO, AltruBio
  • Former SVP/global biotech head/Berkeley site head, Bayer Pharmaceutical
Dr. Vincent S. Tseng

Dr. Vincent S. Tseng

  • IEEE fellow
  • Chair Professor, Department of Computer Science, National Yang Ming Chiao Tung University, Taiwan
Ms. Fran White

Ms. Fran White

  • Founder and President Emerita of MDC Associates, IVD Regulatory Affairs
Dr. Christopher VandenBussche M.D., Ph.D.

Dr. Christopher VandenBussche M.D., Ph.D.

  • Associate Professor of Pathology at The Johns Hopkins University School of Medicine
  • Associate Director, Cytopathology Division at Johns Hopkins Hospital